+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Dihydrocucurbitacin B

BPF2140
13201-14-4
98%
Phytounique
Cucumis melo L.
Dihydrocucurbitacin B has anti-cancer activity, it reduces cell proliferation due to a decrease in the expression of cyclins, mainly cyclin-B1 and disruption of the actin cytoskeleton, arresting B16F10 cells in G2/M phase. Dihydrocucurbitacin B modifies the evolution of the clinical symptoms, reduces the swelling and bone and tissue damage along with the development of the disease, modifies the cell infiltration and the expression of both nitric oxide synthase-2 and cyclooxygenase-2. 23,24-dihydrocucurbitacin B is a 23,24-dihydrocucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at position 5; a hydroxy function at C-25 is acetylated. It is a tertiary alpha-hydroxy ketone, a 23,24-dihydrocucurbitacin and a secondary alpha-hydroxy ketone. It is functionally related to a cucurbitacin B.
Catalog No Package Original Price Price Inventory Quantity Operating
BPF2140-5mg 5mg
BPF2140-10mg 10mg
BPF2140-20mg 20mg
BPF2140-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Product drug property prediction parameters

  • 138.2000

  • 3.2496

  • 3.2493

  • .0137

  • 1.7375

  • 6.6426

  • Low

  • 78.0855

  • 5.3616

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • Yes